Hot Products:
Dx Receptor PAR4 ACE BCR-exon 1/ABL-exon 2 ERalpha HPV-18 K-ras DMD-exon 8 DNMT FV-AS ICAM-1 LMNA-exon 11 Ras p53 ADC COL1A1 CagA/flaA/flaB/vacA GPR75 HBV IL-15

siRNA, Anti-PRKAA1, 2'-F-modified(CAT#: SIRGT17572WQ-2F)

Datasheet

The product SIRGT17572WQ-2F is a type of small interfering RNA (siRNA) that targets PRKAA1 gene and regulates the expression of gene. The siRNA interferes with the expression of PRKAA1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-deoxy-2ʹ-fluoro (2'-F) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification 2ʹ-deoxy-2ʹ-fluoro (2'-F)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_001355028.1; NM_001355029.1; NM_001355034.1; NM_001355035.1; NM_001355036.1; NM_001355037.1; NM_006251.5; NM_206907.3
Alternative Names AMPK; AMPKa1
Related Diseases Wolff-Parkinson-White Syndrome
Purification HPLC
Target Gene
Gene ID 5562
Uniprot ID Q13131

Related Products

siRNA, Anti-Prkaa1, 2'-F-modified (CAT#:SIRGT82017WQ-2F) siRNA, Anti-PRKAA1, 2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified (CAT#:SIRGT16572WQ-2OMe) siRNA, Anti-Prkaa1, 2'-OMe-modified (CAT#:SIRGT81017WQ-2OMe) siRNA, Anti-PRKAA1, Unmodified (CAT#:SIRGT15572WQ)